Skip to Content
Merck
All Photos(1)

Documents

IP10

Millipore

Protein G Plus/Protein A-Agarose

A mixture of Protein G PLUS and Protein A covalently conjugated to agarose. Useful for purification of IgG from biological fluids.

Synonym(s):

Protein G/Agarose

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41116133
NACRES:
NA.56

form

slurry (Liquid)

contains

≤0.1% sodium azide as preservative

manufacturer/tradename

Calbiochem®

storage condition

do not freeze

technique(s)

protein purification: suitable

suitability

suitable for microbiology

shipped in

wet ice

storage temp.

2-8°C

General description

A mixture of Protein G PLUS and Protein A covalently conjugated to agarose. Useful for purification of IgG from biological fluids.
Designed for immunoglobulin purification at low pressure. Product size refers to the volume of packed beads.

Application

Antibody Purification

Warning

Toxicity: Standard Handling (A)

Physical form

50% suspension in PBS.

Other Notes

Note: the product size refers to the volume of packed beads. This product can be used directly with serum, plasma, tissue culture media, ascites, or other biological fluids, but if sufficient quantities of starting material are available we recommend an initial clean up step. The column life will be greatly extended if aggregated proteins and lipids are removed from the immunoglobulin in the clean up step. Use 5-10 ml of packed beads per ml serum.



Recommended Protocol for IgG Purification



Buffers



All concentrations stated are for working solutions, not the 10X concentrates. Caution: sodium azide is poison.



Binding/Washing Buffer: 100 mM sodium phosphate pH 7.0, 150 mM sodium chloride, 5 mM sodium EDTA, 0.01% sodium azide.

Elution Buffer A (see Note section): 500 mM ammonium acetate pH 3.0, 0.01% sodium azide.

Elution Buffer B: 10 mM glycine/HCl pH 3.0, and 0.01% sodium azide.

Neutralization Buffer: 500 mM Tris Base, 0.01% sodium azide.

Storage Buffer: 100 mM sodium phosphate, pH 7.0, 0.01% sodium azide.



Protocol



A. Clean Up and Concentration

Ascites and serum should be clotted at room temperature, refrigerated at 4°C overnight (to allow the clot to shrink and lipids to separate), and centrifuged multiple times to remove all clotted protein and lipid. Remove the lipid from the top of the centrifuge tube with a glass rod or small wooden stick. Tissue culture media should be centrifuged or filtered to remove aggregates.

IgG can be concentrated and partially purified by use of an ammonium sulfate precipitation step. Add ammonium sulfate to 50% saturation (313 g per L) with stirring and check the pH adjusting to 7.0 by addition of 1 M HCl or NaOH. Centrifuge to collect precipitated immunoglobulin, dissolve in binding buffer and dialyze against the same buffer.



B. Purification

1. Pack a column with the Agarose Conjugate.

2. Wash with about 20 column volumes Washing/Binding Buffer until pH of eluate is 7.0.

3. If IgG has not been previously dialyzed against binding buffers dilute or dialyze IgG-containing sample into the Washing/Binding Buffer (pH 6.5-7.5).

4. Load sample onto column.

5. Wash with Washing/Binding Buffer until the absorbance of the eluate at 280 nm approaches background level.

6. Wash with Elution Buffer A to elute IgG, and collect fractions until A280 returns to background levels.

7. Wash with Elution Buffer B, and collect fractions until A280 returns to background. Most IgG should elute with buffer A.

8. Neutralize eluted IgG fractions by addition of an equal volume of neutralization buffer and check the pH with pH paper. For best results, neutralize eluate promptly.

9. To re-use the column immediately, repeat procedure from Step 2.

10. To prepare the column for storage, wash column with 5 column volumes of Elution Buffer B.

11. To store column wash with 30 column volumes storage buffer; then seal column outlets and store in refrigerator.

12. Quantitate the purified IgG using the formula:



Absorbance at 280 nm/1.4 = Concentration (mg/ml).



To make Elution Buffer A, start with acetic acid and adjust the pH to 3.0 with ammonium hydroxide.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Meihan Liu et al.
International journal of biological sciences, 15(3), 617-627 (2019-02-13)
Metformin, a common therapeutics for type 2 diabetics, was recently demonstrated to possess antitumor activity in various cancer types. However, its therapy effect in renal cell carcinoma (RCC) still remains controversial. In this study, we found that metformin treatment in
Paul F Bradfield et al.
Arthritis and rheumatism, 48(9), 2472-2482 (2003-09-18)
A characteristic feature of the inflammatory infiltrate in rheumatoid arthritis is the segregation of CD4 and CD8 T lymphocyte subsets into distinct microdomains within the inflamed synovium. The aim of this study was to test the hypothesis that chemokines in
Michelle A Schultz et al.
PloS one, 9(1), e87204-e87204 (2014-01-28)
Despite androgen deprivation therapy (ADT), persistent androgen receptor (AR) signaling enables outgrowth of castration resistant prostate cancer (CRPC). In prostate cancer (PCa) cells, ADT may enhance AR activity through induction of oxidative stress. Herein, we investigated the roles of Nrf1
Yuge Jiang et al.
Cell death discovery, 8(1), 404-404 (2022-10-02)
Sevoflurane anesthesia is reported to repress neurogenesis of neural stem cells (NSCs), thereby affecting the brain development, but the underlying mechanism of sevoflurane on the proliferation of NSCs remains unclear. Thus, this study aims to discern the relationship between sevoflurane
Aekkachai Tuekprakhon et al.
Cell, 185(14), 2422-2433 (2022-07-01)
The Omicron lineage of SARS-CoV-2, which was first described in November 2021, spread rapidly to become globally dominant and has split into a number of sublineages. BA.1 dominated the initial wave but has been replaced by BA.2 in many countries.

Related Content

We manufacture IP and antibody purification agarose beads that purify immunoglobulins and IgG fractions. Our kits also provide a total antibody purification process

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service